Bioengineer, entrepreneur and investor who has founded or co-founded several venture backed biotech companies including Adimab, Alloy Therapeutics, Compass Therapeutics, Alector, Arsanis and Avitide.
Currently the founder and CEO of Alloy Therapeutics and the founder and CEO of Ulysses Diversified Holdings where he supports entrepreneurially-minded people building for-profit companies that make the world a better place.
Received his MBA from the Tuck School of Business where he graduated as a Tuck Scholar; studied Bioengineering as a graduate student at the Thayer School of Engineering and received his AB in Economics from Dartmouth College where he also played rugby; played rugby during high school in Kansas City, Kansas, where he played lock, flanker and number 8.